Indices
Nifty 5022,427.60−1.15% Nifty Bank54,202.00−1.32% BSE Sensex72,610.34−0.87% Nifty Financial Services24,314.10−1.39% BSE Bankex61,032.88−1.19% Nifty Midcap Select12,966.30−2.62% India VIX16.72+6.09%
Nifty 50
ADANIENT2,470.60−3.11% ADANIPORTS1,695.00−3.14% APOLLOHOSP7,584.50−0.26% ASIANPAINT2,266.00−0.82% AXISBANK1,204.90−0.59% BAJAJ-AUTO10,052.00−1.01% BAJAJFINSV1,643.20−2.07% BAJFINANCE919.95−2.35% BEL356.50−2.19% BHARTIARTL1,864.00−1.64% BSE3,208.50−1.73% CIPLA1,319.30−0.87% COALINDIA392.05−2.61% DRREDDY1,226.70−0.99% EICHERMOT6,967.00−1.66% ETERNAL312.10+2.51% GRASIM2,874.90−0.67% HCLTECH1,424.70+0.21% HDFCBANK694.00−0.01% HDFCLIFE517.25−2.10% HINDALCO862.50−2.61% HINDUNILVR1,784.70−2.38% ICICIBANK1,389.00−0.68% INDIGO4,506.00−2.04% INFY1,158.20+0.42% ITC256.85−0.79% JIOFIN203.65−3.39% JSWSTEEL1,194.70−2.07% KOTAKBANK430.85−1.41% LT3,604.80−0.92% M&M2,816.50−1.66% MARUTI11,061.00−0.98% MAXHEALTH816.10−0.11% NESTLEIND1,160.80−2.45% NTPC293.15−3.12% ONGC225.000.00% POWERGRID242.70−2.29% RELIANCE1,172.50−1.01% SBILIFE1,621.60−1.30% SBIN952.40−1.81% SHRIRAMFIN871.35−3.28% SUNPHARMA1,740.40−1.00% TATACONSUM950.20−1.00% TATASTEEL164.05−4.80% TCS2,540.80+1.35% TECHM1,791.90−2.03% TITAN4,219.10−3.01% TMPV260.80−3.41% TRENT2,691.60−3.03% ULTRACEMCO10,861.00−0.89%
Sign in Get started

Dr. Lal Path Labs share price

Dr. Lal Path Labs Ltd. · NSE: LALPATHLAB · Healthcare

₹1,826.10 −17.60 −0.95%
Nifty 500Nifty PharmaSmall cap
Live · 23 Oct 2026, 12:39 IST

Price, one year

1 year agoLow 1,307.60 · High 2,005.10Latest close
1W−4.87%
1M−3.99%
3M+8.52%
6M+28.30%
1Y+14.40%

Price range

Open
₹1,839.00
High
₹1,848.10
Low
₹1,801.20
Previous close
₹1,843.70
Volume
42,082
Market cap
₹30,651 Cr
Day range
52-week range

Key statistics

Results to 30 Jun 2026 · Consolidated
P/E (TTM)
56.8
Price to book
12.3
Return on equity
21.6%
EPS (TTM)
₹32.45
Book value / share
₹149.43
Debt to equity
0.00
Revenue (TTM)
₹2,891 Cr
Net profit (TTM)
₹542 Cr
Sales growth, YoY
+19.1%
Profit growth, YoY
+28.0%
Operating margin
29.0%
Net margin
18.8%
Sales CAGR, 3 years
+11.1%
Profit CAGR, 3 years
+28.3%
Promoter holding
52.93%
Promoter shares pledged
0.00%
From the company's results filed with NSE; TTM is the last four quarters. Ratios use the latest price.

Shareholding pattern

% of shares
HolderDec 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters53.2153.2153.2153.1952.93
Foreign institutions20.6820.2917.1817.3618.73
Domestic institutions18.9619.2121.3821.5921.58
Mutual funds16.6016.8418.6218.7918.68
Retail and others5.725.826.556.255.29

Results and announcements

Latest results (quarter to 30 Jun 2026) filed 24 Jul 2026. results: 4 Nov 2026.

Exchange filings as published on NSE; routine filings are left out.

Peers in Healthcare

All Healthcare stocks
CompanyPriceChangeMarket capP/E
Sun Pharmaceutical IndustriesSUNPHARMA ₹1,740.40 −1.00% ₹4,17,580 Cr 34.9
Divi's LaboratoriesDIVISLAB ₹8,881.00 −3.07% ₹2,35,763 Cr 83.1
Torrent PharmaceuticalsTORNTPHARM ₹4,487.80 −2.76% ₹1,70,701 Cr 73.7
Zydus LifesciencesZYDUSLIFE ₹1,124.80 −0.90% ₹1,12,199 Cr 25.3
Apollo Hospitals EnterpriseAPOLLOHOSP ₹7,584.50 −0.26% ₹1,09,053 Cr 52.3
CiplaCIPLA ₹1,319.30 −0.87% ₹1,06,582 Cr 31.9
Laurus LabsLAURUSLABS ₹1,943.10 −2.97% ₹1,04,988 Cr 98.8
Dr. Reddy's LaboratoriesDRREDDY ₹1,226.70 −0.99% ₹1,02,390 Cr 32.0
Mankind PharmaMANKIND ₹2,228.10 −2.09% ₹92,031 Cr 46.0
Aurobindo PharmaAUROPHARMA ₹1,557.50 −3.31% ₹89,615 Cr 25.2

Frequently asked questions

What is the share price of Dr. Lal Path Labs today?

Dr. Lal Path Labs (NSE: LALPATHLAB) was at ₹1,826.10 on 23 Oct 2026, a change of −0.95% from the previous close.

What are the 52-week high and low of Dr. Lal Path Labs?

Over the last 52 weeks Dr. Lal Path Labs traded between ₹1,272.60 and ₹2,038.60 (daily highs and lows on NSE on 23 Oct 2026).

What is the market capitalisation of Dr. Lal Path Labs?

About ₹30,651 Cr at the latest price, with a P/E of 56.8, a price-to-book of 12.3, a return on equity of 21.6%. Ratios use the company's latest reported results.

Who owns Dr. Lal Path Labs shares?

According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 52.93%, foreign institutions 18.73%, domestic institutions 21.58%.

Which sector and indices does Dr. Lal Path Labs belong to?

NSE classifies Dr. Lal Path Labs under Healthcare; it is a member of Nifty 500.

Follow Dr. Lal Path Labs with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.

Get started free